1. Home
  2. MAC vs PTCT Comparison

MAC vs PTCT Comparison

Compare MAC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAC
  • PTCT
  • Stock Information
  • Founded
  • MAC 1964
  • PTCT 1998
  • Country
  • MAC United States
  • PTCT United States
  • Employees
  • MAC N/A
  • PTCT N/A
  • Industry
  • MAC Real Estate Investment Trusts
  • PTCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAC Real Estate
  • PTCT Health Care
  • Exchange
  • MAC Nasdaq
  • PTCT Nasdaq
  • Market Cap
  • MAC 4.1B
  • PTCT 4.1B
  • IPO Year
  • MAC 1994
  • PTCT 2013
  • Fundamental
  • Price
  • MAC $16.71
  • PTCT $45.38
  • Analyst Decision
  • MAC Hold
  • PTCT Buy
  • Analyst Count
  • MAC 12
  • PTCT 14
  • Target Price
  • MAC $18.95
  • PTCT $68.07
  • AVG Volume (30 Days)
  • MAC 1.6M
  • PTCT 1.2M
  • Earning Date
  • MAC 08-11-2025
  • PTCT 08-07-2025
  • Dividend Yield
  • MAC 4.07%
  • PTCT N/A
  • EPS Growth
  • MAC N/A
  • PTCT N/A
  • EPS
  • MAC N/A
  • PTCT 7.72
  • Revenue
  • MAC $1,012,216,000.00
  • PTCT $1,764,929,000.00
  • Revenue This Year
  • MAC $12.20
  • PTCT $120.38
  • Revenue Next Year
  • MAC N/A
  • PTCT N/A
  • P/E Ratio
  • MAC N/A
  • PTCT $5.88
  • Revenue Growth
  • MAC 20.66
  • PTCT 96.00
  • 52 Week Low
  • MAC $12.48
  • PTCT $29.02
  • 52 Week High
  • MAC $22.27
  • PTCT $58.38
  • Technical
  • Relative Strength Index (RSI)
  • MAC 50.20
  • PTCT 38.53
  • Support Level
  • MAC $15.94
  • PTCT $44.15
  • Resistance Level
  • MAC $17.30
  • PTCT $51.97
  • Average True Range (ATR)
  • MAC 0.57
  • PTCT 1.95
  • MACD
  • MAC -0.07
  • PTCT -0.01
  • Stochastic Oscillator
  • MAC 38.89
  • PTCT 14.12

About MAC Macerich Company (The)

Macerich invests in premium mall assets. The company owns 29 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with two power centers and seven other real estate assets. The company's total portfolio has 42.1 million square feet of gross leasable area and averaged $837 sales per square foot over the 12 months ended in March 2025.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: